Clinical Trial

A Study Regarding Tissue Response During and After Treatment for Anal Cancer

Study acronym: ANCABio
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: * The tumour microenvironment * The localisation of and cellular interactions between the tumour and immune cells * The gene and protein expression by cells present in the tumour and surrounding tissue.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-07-03; most recent amendment 2025-03-13.
Status change: Active, Not Recruiting → Recruiting 2025-03-13
Status change: Not Yet Recruiting → Active, Not Recruiting 2023-12-07
Trial Details
NCT Number NCT05939401
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Göteborg University
Conditions Anal Cancer
Enrollment 400 participants
Start Date 2023-12-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-18